Top » Catalog » SAINT-PhD

My Account  |  Cart Contents  |  Checkout  
 
Product Information
SAINT-MIX
DNA-Transfection

SAINT-RED
siRNA-Solutions

SAINT-PhD
Protein-delivery

SAINT-18
Primary cells

SAINT-Solid-1
Cationic-lipid

T R A E N

Online Ordering
SAINT-MIX

SAINT-PhD

SAINT-RED

SAINT-18

SAINT-Solid-1

T R A E N
Technical Information
Cell Database
Abstracts
Technology
F.A.Q.
Company Information
About us
Company News
Facilities
Management
Drug Development
Contact Information
Protein transfection reagent SAINT-PhD Protein transfection reagent SAINT-PhD
Several cell lines and primary cells have been successfully profected with the SAINT-PhD Reagent,
including CHO-K1, COS-7 , HeLaS3, U373MG, 3T3, HUVEC and Human Dermal Fibroblasts.

Click below to read more about the great benefits:

- The unique advantages of protein delivery with SAINT-PhD.

- Summary of the key benefits of protein transfection by SAINT-PhD.

- Delivery of IgG-FITC using SAINT-PhD: comparison of the standard and the alternative protocol.

- How SAINT-PhD outperforms the competition.

 
Recent SAINT-PhD article:
Pajak B, Apoptosis. 2008 Apr;13(4):509-22. Bisindolylmaleimide IX facilitates extrinsic and
initiates intrinsic apoptosis in TNF-alpha-resistant human colon adenocarcinoma COLO 205 cells.
(Recombinant biologically functional Bcl-2 protein (R&D Systems Inc., Minneapolis, MN, USA) was
delivered into COLO 205 cells with SAINT-PhD [1-methyl-4-(cis-9-dioleyl)methylpyridinium-chloride
(SAINT-18) 1,2-Dioleyl-sn-glycero-3-phosphoethanolamine (DOPE)] reagent according to the
producer’s instruction (Synvolux Therapeutics, Groningen, The Netherlands).)

1. Van der Gun BT, J Control Release. 2007 Nov 20;123(3):228-38. Epub 2007 Aug 23, Serum
insensitive, intranuclear protein delivery by the multipurpose cationic lipid SAINT-2.
(Profection using Saint-2. “SAINT-2:DOPE (SD; 0.75 mM) and SAINT-2 (S; 0.75 mM) were purchased
from Synvolux Therapeutics Inc.(Groningen, The Netherlands).”)

SAINT-PhD product description and protocols:

SAINT-PhD consists of a proprietary cationic pyridinium amphiphile and a helper lipid.
Upon mixture of SAINT-PhD with the protein a particle of approximately 200nm in diameter is formed. In this particle the protein is enwrapped by at least one bilayer of lipids. Furthermore, in the complex formed only non-covalent interactions are present between SAINT-PhD and the protein. The cationic amphiphiles on the surface of the particle have high affinity for the negatively charged cell surface. Upon fusion or entrapment of the particle the protein is released into the cytoplasm of the cell. The proteins delivered by SAINT-PhD are functional and unmodified.

Protocols:
SAINT-PhD Protocol
SAINT-PHD Sketch

 
Latest News